Skip to contentR
Rockwell Medical, Inc.
R
RMTIRockwell Medical, Inc. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$18.35M$18.35Mderived−25.6% vs Q4 2024 Net Income-$554.00K-$554.00KderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$3,878,000+6.8% Operating Incomederived-$398,000N/M Operating Cash Flowderived$2,291,000+164.9% Free Cash Flowderived$2,205,000+369.1% Margins · derivedGross margin21.1%+6.4 pt vs Q4 2024
Operating margin-2.2%−0.1 pt vs Q4 2024
Net margin-3.0%+0.0 pt vs Q4 2024
ended Dec 31, 2025 · filed Mar 26, 2026 · 85 d after period end